NEW DELHI, June 22 (Xinhua) — Kampani yopanga katemera ku India yotchedwa Bharat Biotech's Covaxin yawonetsa kuti yagwira ntchito bwino ndi 77.8 peresenti mu mayeso a gawo lachitatu, malinga ndi atolankhani ambiri akumaloko Lachiwiri.
"Covaxin ya Bharat Biotech ndi yothandiza kwambiri 77.8 peresenti poteteza ku COVID-19, malinga ndi deta yochokera ku mayeso a gawo lachitatu omwe adachitika pa anthu 25,800 ku India konse," linatero lipotilo.
Kuchuluka kwa mphamvu kunalengezedwa Lachiwiri pambuyo poti komiti ya akatswiri a Drugs Controller General of India (DCGI) (SEC) idakumana ndikukambirana zotsatira zake.
Kampani yopanga mankhwala idapereka deta yoyesera ya gawo lachitatu la katemera ku DCGI kumapeto kwa sabata.
Malipoti ati kampaniyo ikuyembekezeka kuchita msonkhano wa "asanatumize" ndi akuluakulu a World Health Organisation Lachitatu, kuti akambirane za malangizo operekera deta ndi zikalata zofunika.
India idayamba kupereka katemera wa COVID-19 pa Januware 16 popereka katemera awiri opangidwa ku India, omwe ndi Covishield ndi Covaxin.
Bungwe la Serum Institute of India (SII) likupanga Covishield ya ku AstraZeneca-Oxford University, pomwe Bharat Biotech yagwirizana ndi Indian Council of Medical Research (ICMR) popanga Covaxin.
Katemera wa Sputnik V wopangidwa ku Russia nawonso wayamba kugwiritsidwa ntchito mdzikolo.
Nthawi yotumizira: Juni-25-2021